[125i]-(Pyr1)Apelin-13 Is a Novel Radioligand for Localizing the APJ Orphan Receptor in Human and Rat Tissues With Evidence for a Vasoconstrictor Role in Man

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0703939
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Erratum: Human Urotensin-Ii Is a Potent Vasoconstrictor and Agonist for the Orphan Receptor GPR14

Nature
Multidisciplinary
1999English

Synthesis and Characterization of [3h]-Sn56, a Novel Radioligand for the Σ1 Receptor

European Journal of Pharmacology
Pharmacology
2011English

A Novel Cyclic Biased Agonist of the Apelin Receptor, MM07, Is Disease Modifying in the Rat Monocrotaline Model of Pulmonary Arterial Hypertension

British Journal of Pharmacology
Pharmacology
2019English

Metabotropic Glutamate Subtype 5 Receptors Are Quantified in the Human Brain With a Novel Radioligand for PET

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

A Role for the GSG Domain in Localizing Sam68 to Novel Nuclear Structures in Cancer Cell Lines

Molecular Biology of the Cell
Cell BiologyMolecular Biology
1999English

A Role for the Orphan Nuclear Receptor TLX in the Interaction Between Neural Precursor Cells and Microglia

Neuronal Signaling
2019English

Effects of Exercise Combined With Apelin-13 on Cardiac Function in the Isolated Rat Heart

Revista Brasileira de Medicina do Esporte
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
2018English

Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids

Frontiers in Pharmacology
Pharmacology
2018English

Apelin‑13 Ameliorates Metabolic and Cardiovascular Disorders in a Rat Model of Type 2 Diabetes With a High‑fat Diet

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy